Home

előnyös Előfeltétel hosszúság rtx infusion Figyelem Menedéket keresni vérfoltos

a) Dot-blot analysis against rituximab (RTX) or bovine serum albumin... |  Download Scientific Diagram
a) Dot-blot analysis against rituximab (RTX) or bovine serum albumin... | Download Scientific Diagram

Single dose of rituximab in children with steroid-dependent minimal change  nephrotic syndrome
Single dose of rituximab in children with steroid-dependent minimal change nephrotic syndrome

Frontiers | Effectiveness and Safety of Rituximab in Recalcitrant  Pemphigoid Diseases
Frontiers | Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases

APPENDIX 1. | Effectiveness of Rituximab for the Treatment of Rheumatoid  Arthritis in Patients with Prior Exposure to Anti-TNF: Results from the  CORRONA Registry | The Journal of Rheumatology
APPENDIX 1. | Effectiveness of Rituximab for the Treatment of Rheumatoid Arthritis in Patients with Prior Exposure to Anti-TNF: Results from the CORRONA Registry | The Journal of Rheumatology

CD20 before and after infusion of RTX. The '3rd day', '2nd week', '1st... |  Download Scientific Diagram
CD20 before and after infusion of RTX. The '3rd day', '2nd week', '1st... | Download Scientific Diagram

Factors Influencing Infusion-Related Reactions Following Dosing of  Reference Rituximab and PF-05280586, a Rituximab Biosimilar | SpringerLink
Factors Influencing Infusion-Related Reactions Following Dosing of Reference Rituximab and PF-05280586, a Rituximab Biosimilar | SpringerLink

Mean (± SD) plasma rituximab concentration versus time profiles after... |  Download Scientific Diagram
Mean (± SD) plasma rituximab concentration versus time profiles after... | Download Scientific Diagram

Patient characteristics At the time of RTX infusion | Download Table
Patient characteristics At the time of RTX infusion | Download Table

Factors Influencing Infusion-Related Reactions Following Dosing of  Reference Rituximab and PF-05280586, a Rituximab Biosimilar | SpringerLink
Factors Influencing Infusion-Related Reactions Following Dosing of Reference Rituximab and PF-05280586, a Rituximab Biosimilar | SpringerLink

Comparison of Switching from the Originator Rituximab to the Biosimilar  Rituximab GP2013 or Re‑Treatment with the Originator Rituximab in Patients  with Active Rheumatoid Arthritis: Safety and Immunogenicity Results from a  Multicenter, Randomized,
Comparison of Switching from the Originator Rituximab to the Biosimilar Rituximab GP2013 or Re‑Treatment with the Originator Rituximab in Patients with Active Rheumatoid Arthritis: Safety and Immunogenicity Results from a Multicenter, Randomized,

Rituximab abrogates aquaporin-4–specific germinal center activity in  patients with neuromyelitis optica spectrum disorders | PNAS
Rituximab abrogates aquaporin-4–specific germinal center activity in patients with neuromyelitis optica spectrum disorders | PNAS

A New Schedule of CHOP/Rituximab Plus Granulocyte-Macrophage  Colony-Stimulating Factor Is an Effective Rescue for Patients with  Aggressive Lymphoma Failing Autologous Stem Cell Transplantation - Biology  of Blood and Marrow Transplantation
A New Schedule of CHOP/Rituximab Plus Granulocyte-Macrophage Colony-Stimulating Factor Is an Effective Rescue for Patients with Aggressive Lymphoma Failing Autologous Stem Cell Transplantation - Biology of Blood and Marrow Transplantation

A,B) Changes in CD19+ B cell frequency before and after the first... |  Download Scientific Diagram
A,B) Changes in CD19+ B cell frequency before and after the first... | Download Scientific Diagram

Factors Influencing Infusion-Related Reactions Following Dosing of  Reference Rituximab and PF-05280586, a Rituximab Biosimilar | SpringerLink
Factors Influencing Infusion-Related Reactions Following Dosing of Reference Rituximab and PF-05280586, a Rituximab Biosimilar | SpringerLink

Rituximab-induced lung disease: a systematic literature review | European  Respiratory Society
Rituximab-induced lung disease: a systematic literature review | European Respiratory Society

A, ECG prior to RTX infusion. B, Occurrence of PVC during RTX infusion....  | Download Scientific Diagram
A, ECG prior to RTX infusion. B, Occurrence of PVC during RTX infusion.... | Download Scientific Diagram

A, ECG prior to RTX infusion. B, Occurrence of PVC during RTX infusion....  | Download Scientific Diagram
A, ECG prior to RTX infusion. B, Occurrence of PVC during RTX infusion.... | Download Scientific Diagram

Sustained Low Relapse Rate With Highly Variable B-Cell Repopulation  Dynamics With Extended Rituximab Dosing Intervals in Multiple Sclerosis |  Neurology Neuroimmunology & Neuroinflammation
Sustained Low Relapse Rate With Highly Variable B-Cell Repopulation Dynamics With Extended Rituximab Dosing Intervals in Multiple Sclerosis | Neurology Neuroimmunology & Neuroinflammation

Tolerability and Safety of Switching from Rituximab to Ocrelizumab:  Evaluating Factors Associated with Infusion Related Reactions - Enrique  Alvarez, Kavita V. Nair, Stefan Sillau, Ian Shelton, Rebecca Seale, Sean  Selva, John Corboy,
Tolerability and Safety of Switching from Rituximab to Ocrelizumab: Evaluating Factors Associated with Infusion Related Reactions - Enrique Alvarez, Kavita V. Nair, Stefan Sillau, Ian Shelton, Rebecca Seale, Sean Selva, John Corboy,

Compassionate open-label use of rituximab following a randomised clinical  trial against neuromyelitis optica (RIN-2 study): B cell monitoring-based  administration - ScienceDirect
Compassionate open-label use of rituximab following a randomised clinical trial against neuromyelitis optica (RIN-2 study): B cell monitoring-based administration - ScienceDirect

Effectiveness and safety of Rituximab in multiple sclerosis: an  observational study from Southern Switzerland | PLOS ONE
Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland | PLOS ONE

Frontiers | Rituximab Therapy for Primary Sjögren's Syndrome
Frontiers | Rituximab Therapy for Primary Sjögren's Syndrome